Skip to content
Nonprofiteer
← REGENERATIVE RESEARCH FOUNDATION

Form 990 for tax year 2022

Filed by REGENERATIVE RESEARCH FOUNDATION.

Totals

Total revenue
$7,532,149
Total expenses
$5,849,247
Contributions and grants received
$6,469,338
Grants paid
$0
Program service revenue
$577,571
Investment income
$204
Other revenue
$485,036
Total assets, end of year
$5,981,949
Total liabilities, end of year
$1,959,438
Net assets or fund balances, end of year
$4,022,511
Program services expenses (Part IX)
$5,008,416
Management and general expenses
$840,831
Fundraising expenses
$0
Program service expenses (Part III)
$5,008,416

Program services were 85.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $5,578,681

  • 1f · All other contributions, gifts and grants

    $890,657

  • 2a · Program service revenue: SPONSORED RESEARCH

    total $577,571 · related or exempt $577,571

  • 3 · Investment income

    total $204 · excluded $204

  • 5 · Royalties

    total $27,604 · excluded $27,604

  • 11a · Other revenue: NEURACELL INCOME

    total $457,432 · excluded $457,432

  • 11e · Other revenue, total

    $457,432

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $230,939 · program services $230,939

  • 7 · Other salaries and wages

    total $2,069,236 · program services $1,692,703 · management and general $376,533

  • 8 · Pension plan contributions

    total $62,062 · program services $51,162 · management and general $10,900

  • 9 · Other employee benefits

    total $224,739 · program services $188,894 · management and general $35,845

  • 10 · Payroll taxes

    total $166,215 · program services $139,967 · management and general $26,248

  • 11b · Fees: legal

    total $148,337 · program services $145,832 · management and general $2,505

  • 11c · Fees: accounting

    total $20,518 · management and general $20,518

  • 11g · Fees: other

    total $169,317 · program services $113,443 · management and general $55,874

  • 13 · Office expenses

    total $26,562 · program services $8,123 · management and general $18,439

  • 14 · Information technology

    total $21,165 · program services $2,330 · management and general $18,835

  • 16 · Occupancy

    total $351,707 · program services $339,891 · management and general $11,816

  • 17 · Travel

    total $37,778 · program services $33,245 · management and general $4,533

  • 19 · Conferences, conventions and meetings

    total $16,145 · program services $8,763 · management and general $7,382

  • 22 · Depreciation, depletion and amortization

    total $54,711 · program services $54,711

  • 23 · Insurance

    total $27,919 · management and general $27,919

  • 24a · Other expenses: RESEARCH SUBCONTRACTS

    total $1,042,391 · program services $1,042,391

  • 24b · Other expenses: LABORATORY CHARGES

    total $1,018,935 · program services $846,304 · management and general $172,631

  • 24c · Other expenses: EQUIP. REPAIR & MAINT.

    total $106,477 · program services $105,510 · management and general $967

  • 24d · Other expenses: BAD DEBT

    total $37,571 · program services $0 · management and general $37,571

  • 24e · All other expenses

    total $16,523 · program services $4,208 · management and general $12,315

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $282,539 · end of year $678,162

  • 2 · Savings and temporary cash investments

    beginning of year $1,382,853 · end of year $1,931,726

  • 3 · Pledges and grants receivable

    beginning of year $939,297 · end of year $1,693,916

  • 4 · Accounts receivable

    beginning of year $92,222 · end of year $203,006

  • 9 · Prepaid expenses and deferred charges

    beginning of year $139,782 · end of year $120,161

  • 10a · Land, buildings and equipment: cost or other basis

    $3,709,609

  • 10b · Land, buildings and equipment: accumulated depreciation

    $3,616,608

  • 10c · Land, buildings and equipment, net

    beginning of year $119,505 · end of year $93,001

  • 15 · Other assets

    beginning of year $1,562,563 · end of year $1,261,977

  • 17 · Accounts payable and accrued expenses

    beginning of year $605,389 · end of year $711,170

  • 25 · Other liabilities

    beginning of year $1,573,763 · end of year $1,248,268

  • 27 · Net assets without donor restrictions

    beginning of year $1,454,706 · end of year $3,024,854

  • 28 · Net assets with donor restrictions

    beginning of year $884,903 · end of year $997,657

Mission and programs · 2022

Mission

THE PRINCIPAL MISSION OF THE REGENERATIVE RESEARCH FOUNDATION IS TO DEVELOP REGENERATIVE STEM CELL THERAPIES FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS): THE BRAIN, SPINAL CORD, AND RETINA.

  • FISCAL YEAR 2022 SAW THE REGENERATIVE RESEARCH FOUNDATION'S OPERATIONS RETURN TO A MORE NORMAL LEVEL OF ACTIVITY. THE LABORATORIES WERE FULLY STAFFED, AND THE FOUNDATION RENEWED ITS COMMITMENT TO PURSUING ITS MISSION TO DEVELOP POTENTIAL THERAPIES FOR TREATMENT FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM. FOUNDATION RESEARCHERS PUBLISHED A TOTAL OF SEVEN ARTICLES REPORTING THE RESULTS OF THEIR INVESTIGATIONS IN SEVERAL PROMINENT SCIENTIFIC JOURNALS. THE TOPICS INCLUDED NEURODEGENERATIVE, EYE AND ALZHEIMER'S DISEASE. THESE ARTICLES ARE MADE AVAILABLE FREELY TO THE SCIENTIFIC COMMUNITY AND THE GENERAL PUBLIC THROUGH THE NATIONAL INSTITUTES OF HEALTH PUB-MED CENTRAL PUBLICATION RETRIEVAL SYSTEM. INVESTIGATORS AT THE FOUNDATION WERE ABLE TO SECURE 10 NEW RESEARCH GRANTS TO CONTINUE AND EXPAND THE STEM CELL RESEARCH PROGRAMS.

    Expenses $1,683,832 · Revenue $327,571

  • THE FOUNDATION INITIATED ITS PLANNED CLINICAL TRIAL DURING FISCAL YEAR 2022 AFTER SURMOUNTING NUMEROUS OBSTACLES INCLUDING THE PANDEMIC AND RETINAL STEM CELL PRODUCT MANUFACTURING DELAYS. THREE STUDY SUBJECTS RECEIVED THE RETINAL PIGMENT EPITHELIUM STEM CELL REPLACEMENT THERAPY DEVELOPED BY THE FOUNDATION. THE RESULTS OF THIS THERAPEUTIC INTERVENTION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION ARE PROMISING. THE FOUNDATION HOPES TO EXPAND THESE CLINICAL STUDIES WITH ITS BIOTECHNOLOGY PARTNERSHIP AND MAKE THE THERAPY READILY AVAILABLE TO THOSE SUFFERING FROM AMD.

    Expenses $1,176,261 · Revenue $250,000

  • THE ALZHEIMER'S AND RELATED DEMENTIA RESEARCH PROGRAM CONTINUED ITS INVESTIGATIONS INTO THE CAUSES AND TREATMENT OF THESE DISEASES. THE FOUNDATION ALSO EXPANDED ITS DEMENTIA PROGRAM BY ESTABLISHING SEVERAL COLLABORATIVE ARRANGEMENTS INCLUDING A PROJECT INVOLVING FIVE COLLABORATIVE LABORATORIES AT DIFFERENT ACADEMIC INSTITUTIONS. SUPPORT FOR THESE ENDEAVORS WAS PROVIDED BY THE NATIONAL INSTITUTES OF HEALTH AND VARIOUS PUBLIC CHARITIES. IN ADDITION, THE FOUNDATION ENTERED INTO AN AGREEMENT WITH A BIOTECHNOLOGY COMPANY TO RESEARCH A POTENTIAL NEURODEGENERATIVE DISEASE TREATMENT.

    Expenses $2,148,323

As filed on the 2022 return.

Listed in Part VII

  • William Kahn CPA

    CHAIR

    Total calculated
    $0
    Hours/week
    5

  • Jeffrey H Stern MD PhD

    DIRECTOR FOR TRANSLATIONAL

    Total calculated
    $47,886
    From this org
    $47,400
    From related orgs
    $0
    Other
    $486
    Hours/week
    30

  • John Walsh

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2

  • Vito Grasso Mpa Cae

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • David O Carpenter MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Dawn Abbuhl

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Robert Catalano MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Amy G Klann PhD JD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Sally Temple-Stern PhD

    SCIENTIFIC & EXECUTIVE DIR

    Total calculated
    $183,053
    From this org
    $174,326
    From related orgs
    $0
    Other
    $8,727
    Hours/week
    70

    Schedule J breakdown matched by us

    Base
    $174,326
    Bonus
    $0
    Other
    $0
    Deferred
    $6,962
    Nontaxable benefits
    $1,765
    Filer's total
    $183,053

  • Caitlin Hill

    PRINCIPAL INVESTIGATOR

    Total calculated
    $135,878
    From this org
    $129,400
    From related orgs
    $0
    Other
    $6,478
    Hours/week
    50

  • Thomas Irwin

    ADMINISTRATIVE DIRECTOR

    Total calculated
    $112,545
    From this org
    $101,236
    From related orgs
    $0
    Other
    $11,309
    Hours/week
    36

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Form 990 of other organizations
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2022
Filed
19 September 2023
IRS schema version
2022v5.0
Source object
202322759349301022

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.